Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00764504 · ClinicalTrials.gov registry record · Phase 3
Reverse Shoulder Prosthesis Study
A Phase 3 study, sponsored by Encore Medical, L.P..
- Completed
- Registry status
- Phase 3
- Development phase
- 516
- Enrollment target
NCT00764504 is a Phase 3 study that has completed, run by Encore Medical, L.P.. The registered enrollment target is 516 participants.
The verdict
NCT00764504, a Phase 3 study, has completed, sponsored by Encore Medical, L.P..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 516 participants
- Enrollment target
Study Summary
The objective of this clinical study is to evaluate the safety and efficacy of the Encore Reverse Shoulder Prosthesis (RSP). The clinical results of the RSP will be compared to clinical results published in literature for rotator cuff arthropathy and salvage procedures.
Interventions
- DEVICE Reverse Shoulder Prosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 516 participants |
| Start Date | 2002-10 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00764504
The ClinicalTrials.gov registry entry for NCT00764504 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 516 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Encore Medical, L.P., which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reverse Shoulder Prosthesis is the first listed.
NCT00764504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00764504 about?
NCT00764504 is a clinical study titled "Reverse Shoulder Prosthesis Study". The objective of this clinical study is to evaluate the safety and efficacy of the Encore Reverse Shoulder Prosthesis (RSP). The clinical results of the RSP will be compared to clinical results published in literature for rotator cuff arthropathy and salvage procedures.
What is the current status of trial NCT00764504?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 516 participants. The study started on 2002-10. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00764504?
The interventions under investigation include: Reverse Shoulder Prosthesis (DEVICE).
Who is sponsoring clinical trial NCT00764504?
This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.